InvestorsHub Logo
Followers 28
Posts 6019
Boards Moderated 0
Alias Born 10/30/2013

Re: bow-tie post# 24381

Monday, 04/19/2021 10:38:12 PM

Monday, April 19, 2021 10:38:12 PM

Post# of 27659
Award Information | HHS TAGGS
taggs.hhs.gov › Detail › AwardDetail
Apr 14, 2021 · To improve immunogenicity, Mymetics has embedded the toll-like receptor (TLR)7/8 adjuvant 3M-052 into virosomal envelopes. Moreover, Mymetics has developed a powdered form of virosomes that is no longer cold-chain dependent and can be administered as intranasal (IN) spray, sublingual (SL) tablets, or packaged into oral capsules.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News